vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
rukobia
viiv healthcare b.v. - fostemsavir trometamol - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.
sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.
darunavir medical valley filmuhúðuð tafla 600 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 600 mg
darunavir medical valley filmuhúðuð tafla 800 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 800 mg
candizol hart hylki 150 mg
actavis group ptc ehf. - fluconazolum inn - hart hylki - 150 mg
candizol hart hylki 200 mg
actavis group ptc ehf. - fluconazolum inn - hart hylki - 200 mg
candizol hart hylki 50 mg
actavis group ptc ehf. - fluconazolum inn - hart hylki - 50 mg
daivobet hlaup 50 míkróg/g /0,5 mg/g
leo pharma a/s* - calcipotriolum inn; betamethasonum díprópíónat - hlaup - 50 míkróg/g /0,5 mg/g
enstilar húðfroða 50 míkróg/0,5 mg/g
leo pharma a/s* - calcipotriolum inn; betamethasonum díprópíónat - húðfroða - 50 míkróg/0,5 mg/g